Restorative and Technological Approaches for Diagnosis and Treatment of Infertility: Pro et Contra.

Presented by: Craig Turczynski, PhD. ALS-P(AAB) (Andrology Laboratory Scientist-Provisional). Texas, USA.

Dr. Craig Turczynski holds a Ph.D. in Physiology of Reproduction and completed a post-doctoral fellowship in reproductive endocrinology at the Women’s Research Institute in Wichita, KS. He then became an Assistant Professor of ObGyn at Louisiana State University Medical School-Shreveport, where he developed and directed their clinical hormone, andrology, and IVF laboratories. After 7 years, he left the IVF field due to conflicts with the aggressive use of the technology. Subsequently, he received training in the Creighton Model and the Billings Ovulation Method®, and also completed the FEMM medical management training, and a fellowship in RRM with Dr. Phil Boyle. He was recently recertified as an andrology laboratory scientist. He believes in the intersection of virtue and science and aligns himself with organizations that seek the root cause of disease and therapeutic cures. Currently, he consults the male spouse of infertility patients on telehealth platforms from My Catholic Doctor and FEMM. His experience performing semen testing and IVF gives him a unique understanding of gamete physiology.

References

  1. Vander Borght M, Wyns C. Fertility and infertility: Definition and epidemiology. Clin Biochem. 2018;62:2-10. doi:10.1016/j.clinbiochem.2018.03.012
  2. Centers for Disease Control and Prevention. 2019 Assisted Reproductive Technology Fertility Clinic and National Summary Report. US Dept of Health and Human Services; 2021. CDC Archives. Cdc.gov. https://archive.cdc.gov/#/details?url=https://www.cdc.gov/art/reports/2019/pdf/2019-Report-ART-Fertility-Clinic-National-Summary-h.pdf
  3. National Summary Report. Sartcorsonline.com. Published 2022. https://sartcorsonline.com/Csr/Public?ClinicPKID=0&reportingYear=2022&newReport=True
  4. Stanford, J.B., Carpentier, P.A., Meier, B.L. et al. Restorative reproductive medicine for infertility in two family medicine clinics in New England, an observational study. BMC Pregnancy Childbirth 21, 495 (2021). https://doi.org/10.1186/s12884-021-03946-8
  5. Leslie SW, Soon-Sutton TL, Khan MAB. Male Infertility. In: StatPearls. Treasure Island (FL): StatPearls Publishing; February 25, 2024.
  6. National Summary Report. Sartcorsonline.com. Published 2021. https://sartcorsonline.com/Csr/Public?ClinicPKID=0&reportingYear=2021&newReport=True#patient-first-attempt
  7. Sullivan-Pyke CS, Senapati S, Mainigi MA, Barnhart KT. In Vitro fertilization and adverse obstetric and perinatal outcomes. Semin Perinatol. 2017;41(6):345-353. doi:10.1053/j.semperi.2017.07.001
  8. Qin J, Sheng X, Wu D, et al. Adverse Obstetric Outcomes Associated With In Vitro Fertilization in Singleton Pregnancies. Reprod Sci. 2017;24(4):595-608. doi:10.1177/1933719116667229
  9. Marino JL, Moore VM, Willson KJ, et al. Perinatal outcomes by mode of assisted conception and sub-fertility in an Australian data linkage cohort. PLoS One. 2014;9(1):e80398. Published 2014 Jan 8. doi:10.1371/journal.pone.0080398
  10. Hill JR. Incidence of abnormal offspring from cloning and other assisted reproductive technologies. Annu Rev Anim Biosci. 2014;2:307-321. doi:10.1146/annurev-animal-022513-114109
  11. Bouchard TP, Fehring RJ, Schneider MM. Achieving Pregnancy Using Primary Care Interventions to Identify the Fertile Window. Front Med (Lausanne). 2018;4:250. Published 2018 Jan 9. doi:10.3389/fmed.2017.00250
  12. Here are the references organized in AMA style:
  13. Johnson MH. IVF: The women who helped make it happen. Reprod Biomed Soc Online. 2018;8:1-6. doi:10.1016/j.rbms.2018.11.002. PMID: 30723816; PMCID: PMC6352853.
  14. A Matter of Life. Robert Edwards & Patrick Steptoe. 1980.
  15. Biggers JD. IVF and embryo transfer: historical origin and development. Reprod Biomed Online. 2012;25(2):118-127. doi:10.1016/j.rbmo.2012.04.011. PMID: 22695311.
  16. Johnson MH. Robert Edwards: the path to IVF. Reprod Biomed Online. 2011;23(2):245-262. doi:10.1016/j.rbmo.2011.04.010. PMID: 21680248; PMCID: PMC3171154.
  17. Chang M. Fertilization of rabbit ova in vitro. Nature. 1959;184:466-467.
  18. Edwards RG, Bavister BD, Steptoe PC. Early stages of fertilization in vitro of human oocytes matured in vitro. Nature. 1969;221:632-635.
  19. Chen M, Heilbronn LK. The health outcomes of human offspring conceived by ART. J Dev Orig Health Dis. 2017;8(4):388-402.
  20. Zhu JL, Basso O, Obel C, et al. Parental infertility and cerebral palsy in children. Hum Reprod. 2010;25(12):3142-3147.
  21. Luke B, Brown MB, Wantman E, et al. The risk of birth defects with conception by ART. Hum Reprod. 2021;36(1):116-129.
  22. Hill JR. Incidence of abnormal offspring from cloning and other assisted reproductive technologies. Annu Rev Anim Biosci. 2014;2:307-321.
  23. Farin CE, Farin PW, Piedrahita JA. Development of fetuses from in vitro-produced and cloned bovine embryos. J Anim Sci. 2004;82:1-10.
  24. Sunkara SK, Rittenberg V, Raine-Fenning N, et al. Association between the number of eggs and live birth in IVF treatment: an analysis of 400,135 treatment cycles. Hum Reprod. 2011;26(7):1768-1774.
  25. Dusenbery M. What we don’t know about IVF. The New York Times. September 2020.
  26. Marshell H, Tham EB, Lin L, et al. Stratification of fertility potential according to cervical mucus symptoms: achieving pregnancy in fertile and infertile couples. Hum Fertil (Camb). 2019;22(3):216-224.
  27. James A, Stanford JB, Porucznik CA, et al. Pregnancy outcomes from a restorative infertility treatment model: a single centre case series. medRxiv. Preprint posted online June 21, 2021. doi:10.1101/2021.06.21.21259218.
  28. Stanford JB, Porucznik CA, Thoma ME, et al. Restorative reproductive medicine for infertility in two family medicine clinics in New England, an observational study. BMC Pregnancy Childbirth. 2021;21(495). doi:10.1186/s12884-021-03994-y.
  29. Stanford JB, Porucznik CA, Thoma ME, et al. International Natural Procreative Technology Evaluation and Surveillance of Treatment for Subfertility (iNEST): enrollment and methods. Hum Reprod Open. 2022;2022(3):hoac027. doi:10.1093/hropen/hoac027.
  30. Tham E, Schliep K, Stanford J. Natural procreative technology for infertility and recurrent miscarriage: outcomes in a Canadian family practice. Can Fam Physician. 2012;58(5):e267-e274.
  31. Boyle PC, de Groot T, Andralojc KM, Parnell TA. Healthy Singleton Pregnancies From Restorative Reproductive Medicine (RRM) After Failed IVF. Front Med (Lausanne). 2018;5:210. Published 2018 Jul 31. doi:10.3389/fmed.2018.00210
  32. Stanford JB, Parnell TA, Boyle PC. Outcomes from treatment of infertility with natural procreative technology in an Irish general practice [published correction appears in J Am Board Fam Med. 2008 Nov-Dec;21(6):583]. J Am Board Fam Med. 2008;21(5):375-384. doi:10.3122/jabfm.2008.05.070239